- Lab Tests
- Health Corner
TARGIT 80MG TABLET contains Telmisartan which belongs to the group of medicines called Angiotensin II receptor antagonists. It is used to treat essential hypertension in adults. High blood pressure that is not caused by any other condition is called as essential hypertension. It is characterized by symptoms such as early morning headaches, nosebleeds, irregular heartbeat, vision changes, buzzing in the ears, fatigue, nausea and chest pain.
It is also used to reduce the risk of cardiovascular events such as heart attack or stroke in adults who are known to have a reduced or blocked blood supply to the heart or legs and had a stroke or with a high risk of diabetes.
Your doctor may check your kidney function test, blood pressure and the amount of electrolytes (Ex. potassium) in your body prior to the treatment or at regular intervals during treatment with this medicine.
TARGIT 80MG TABLET is not recommended for use in patients having severe liver problems such as cholestasis or biliary obstruction (flow of bile from liver stops or slows). TARGIT 80MG TABLET should be used with caution in patients having diabetes, kidney disease, heart problems and raised aldosterone levels.
TARGIT 80MG TABLET is not recommended for use in early pregnancy and must not be taken by women who are pregnant for more than 3 months and it is not recommended for use in breastfeeding women.
TARGIT 80MG TABLET is not recommended for use in children and adolescents (up to the age of 18 years) and it should be used with caution in elderly patients (aged 65 years and above).
The most common side effect of taking TARGIT 80MG TABLET is low blood pressure. Consult your doctor if the symptom worsens.
TARGIT 80MG TABLET makes blood vessels to relax and thus lowers the blood pressure by blocking the effects of Angiotensin II (substance produced in your body which causes narrowing of blood vessels).
Take TARGIT 80MG TABLET as advised by your physician. Swallow this medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of TARGIT 80MG TABLET for you depending upon your age, body weight and disease condition.
• low blood pressure
Stop taking TARGIT 80MG TABLET and contact your doctor immediately if you experience any of the following side effects:
Take TARGIT 80MG TABLET with or just after meals. Stick to simple meals. Avoid eating oil rich or spicy foods, sugary snacks and drinks. Avoid drinking too much liquid along with your meals. Consult your doctor if your symptom does not improve.
Drink lot of fluids such as water or fruit juice to keep yourself hydrated. Do not consume any medicine on your own to treat without consulting your doctor.
Try to rest and relax. Try to have smaller and frequent meals. Keep a heat pad on your stomach. If the symptom does not improve, consult your doctor.
Try to rest and relax. Get enough sleep. Avoid driving or operating any tools or machines while you are feeling dizzy. Do not consume too much of alcohol, as it can aggravate your dizziness. Consult your doctor if the symptom did not improve.
TARGIT 80MG TABLET is not recommended in early pregnancy and must not be taken when more than 3 months pregnant, as it may cause serious harm to the baby if used after 3 months of pregnancy. Consult your doctor before taking TARGIT 80MG TABLET.
TARGIT 80MG TABLET is not recommended for use in breastfeeding women. Your doctor may choose another treatment especially if you want to breast-feed when your baby is new-born or born prematurely. Consult your doctor for advice before taking TARGIT 80MG TABLET.
Do not drive or operate any machines if you feel dizzy or tired after taking TARGIT 80MG TABLET. Consult your doctor before taking TARGIT 80MG TABLET.
Avoid consumption of alcohol as it may increase the risk of low blood pressure.
TARGIT 80MG TABLET should be taken with caution in patients with kidney disease, kidney artery stenosis (narrowing of blood vessels to one or both the kidneys) and with a history of kidney transplant. Consult your doctor before taking TARGIT 80MG TABLET.
TARGIT 80MG TABLET is not recommended for use in patients with severe liver problems such as cholestasis or biliary obstruction (flow of bile from liver stops or slows). TARGIT 80MG TABLET should be used with caution in patients with liver diseases. Consult your doctor before taking TARGIT 80MG TABLET.
TARGIT 80MG TABLET is not recommended for use if you are allergic to Telmisartan or any other ingredients of this medicine.
TARGIT 80MG TABLET should be taken with caution in patients having heart trouble or low blood pressure (due to dehydration problems, low-salt intake, diarrhoea or vomiting). Before taking TARGIT 80MG TABLET consult with your doctor.
Before taking TARGIT 80MG TABLET, inform your doctor if you have:
Use in pediatrics:
TARGIT 80MG TABLET is not recommended for use in children and adolescents (under 18 years of age). Consult your child’s doctor for advice.
Use in geriatrics:
TARGIT 80MG TABLET should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking this medicine.
A. Drug - Drug interactions:
Before taking TARGIT 80MG TABLET, inform your doctor if you are taking any of the following medicines:
If you or anyone else accidentally take too much of TARGIT 80MG TABLET, consult your doctor immediately or visit the nearby hospital. The most common symptoms of overdose are low blood pressure, fast or slow heartbeat, dizziness, elevated levels of creatinine and sudden kidney failure.
|Pharmacological Category||:||Angiotensin receptor blockers|
|Therapeutic Indication||:||Essential hypertension, prevention of heart attack and stroke|
Can TARGIT 80MG TABLET be used to treat high blood pressure?
TARGIT 80MG TABLET can be considered as a drug of choice for high blood pressure. It contains telmisartan which helps to relax the blood vessels and then normalize the blood pressure. Although, TARGIT 80MG TABLET can treat high blood pressure, you doctor might treat you with other drugs depending upon your condition.
Can TARGIT 80MG TABLET cause slow heart rate?
Yes, TARGIT 80MG TABLET can make your heart to beat slow. If you experience any abnormally slow heart rate with shortness of breath, feeling of fainting and spinning sensation (vertigo) consult your doctor immediately.
What precautions do I need to follow while taking TARGIT 80MG TABLET?
Patients taking TARGIT 80MG TABLET must inform their doctor about their pre-existing disease conditions like kidney, heart or liver problems. Consult your doctor immediately if you experience any unusual symptoms after taking TARGIT 80MG TABLET.
What happens if I stop taking TARGIT 80MG TABLET?
Do not stop taking TARGIT 80MG TABLET without talking to your doctor first. Stopping this medicine suddenly can cause your blood pressure to spike and may increase the risk for heart attack or stroke.
Is TARGIT 80MG TABLET safe to use in patients with kidney problems?
TARGIT 80MG TABLET should be taken with caution in patients with kidney disease, kidney artery stenosis (narrowing of blood vessels to one or both the kidneys) and with a history of kidney transplant. Your doctor may assess your kidney functioning during treatment with this medicine to prevent the risk of kidney damage or any unusual effects. Consult your doctor before taking TARGIT 80MG TABLET.
How long should TARGIT 80MG TABLET be taken?
TARGIT 80MG TABLET does not cure high blood pressure but controls it. Your blood pressure may decrease during the first 2 weeks of treatment, but it may take 4 weeks for you to notice the full benefit of this medicine. Consult your doctor for the exact duration of recommendation for you.
1. KD. Tripathi. Drugs Affecting Renin Angiotensin System. Essentials of medical pharmacology. Eighth edition. 2019. Page – 535-538.
2. Philippe Gosse. A Review of Telmisartan in the Treatment of Hypertension: Blood Pressure Control in the Early Morning Hours. NIH National Library of Medicine, National center for biotechnology information. PubMed Central. September 2006. [Accessed on 7th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993985/
3. A Prem Kumar, Anirudra Ghorai, Vasudev Kriplani, Rabindra Kumar Dash, J Aravinda, Paramesh Shamanna, TK Sabeer, Abdul Hannan, and Santosh Revankar. Clinical data analysis of telmisartan for hypertension management in Indian population. NIH National Library of Medicine, National center for biotechnology information. PubMed Central June 2021. [Accessed on 7th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819792/
4. Accord Healthcare Ireland Limited. Health Products Regulatory Authority (HPRA). [Revised in July 2021] [Accessed on 7th May 2022] http://www.hpra.ie/img/uploaded/swedocuments/8c0fc811-cf88-4bd5-818e-609e07fe1190.pdf
5. Hetero Labs Limited. U.S. Food & Drug Administration. [Revised in August 2015] [Accessed 7th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205901Orig1s000lbl.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.